日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting

口咽癌退伍军人风险分层和治疗方面的创新;2019 年实地会议路线图

Sandulache, V C; Lei, Y L; Heasley, L E; Chang, M; Amos, C I; Sturgis, E M; Graboyes, E; Chiao, E Y; Rogus-Pulia, N; Lewis, J; Madabhushi, A; Frederick, M J; Sabichi, A; Ittmann, M; Yarbrough, W G; Chung, C H; Ferrarotto, R; Mai, Weiyuan; Skinner, H D; Duvvuri, U; Gerngross, P; Sikora, A G

Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma

颈部影像报告和数据系统3类和4类治疗后FDG-PET/CT在头颈部鳞状细胞癌中的阳性预测值

Wangaryattawanich, P; Branstetter, B F; Ly, J D; Duvvuri, U; Heron, D E; Rath, T J

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

一项针对局部晚期头颈癌患者的II期随机试验,比较了放射治疗、西妥昔单抗和培美曲塞联合或不联合贝伐珠单抗的疗效。

Argiris, A; Bauman, J E; Ohr, J; Gooding, W E; Heron, D E; Duvvuri, U; Kubicek, G J; Posluszny, D M; Vassilakopoulou, M; Kim, S; Grandis, J R; Johnson, J T; Gibson, M K; Clump, D A; Flaherty, J T; Chiosea, S I; Branstetter, B; Ferris, R L

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

对高危头颈癌切除患者进行术后放疗联合顺铂加帕尼单抗治疗的 II 期试验

Ferris R L, Geiger J L, Trivedi S, Schmitt N C, Heron D E, Johnson J T, Kim S, Duvvuri U, Clump D A, Bauman J E, Ohr J P, Gooding W E, Argiris A

Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation

经口机器人根治性手术与根治性放化疗治疗口咽鳞状细胞癌患者的肿瘤学结果和患者报告的生活质量

Ling, D C; Chapman, B V; Kim, J; Choby, G W; Kabolizadeh, P; Clump, D A; Ferris, R L; Kim, S; Beriwal, S; Heron, D E; Duvvuri, U

Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer

PET/CT监测在头颈部鳞状细胞癌中的阴性预测值

McDermott, M; Hughes, M; Rath, T; Johnson, J T; Heron, D E; Kubicek, G J; Kim, S W; Ferris, R L; Duvvuri, U; Ohr, J P; Branstetter, B F